Product Information
METRONIDAZOLE 500 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1094 per EA under NDC 65862069550. Its NADAC has been published 507 times since Dec 9, 2015.
FDA first approved this application on May 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862069550
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203974FDA Approved
5/29/2015
TE Code
AB
On Market Since
5/29/2015
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 500 MG TABLET has been published 507 times since Dec 9, 2015, and over the history we have for it it has declined 74.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1094 per EA |
|---|---|
| All-time high | $0.4502 (Feb 10, 2016) |
| All-time low | $0.0797 (Nov 20, 2024) |
| Median price | $0.1565 |
| Average price | $0.2064 |
| Largest weekly change | +39.1% (Jun 19, 2024) |
| Weeks tracked | 507 |
| Tracking since | Dec 9, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-17.7%
5Y
-26.7%
All
-74.3%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1094 per EA (NDC 65862069550), effective Aug 20, 2025.
How has the price of METRONIDAZOLE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 74.3%. It has been tracked across 507 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?
Since Dec 9, 2015, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.4502 (Feb 10, 2016), with a median of $0.1565 per EA.
Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE 500 MG TABLET, is $0.1012 per EA — about 8% below METRONIDAZOLE 500 MG TABLET.
Who manufactures METRONIDAZOLE 500 MG TABLET?
METRONIDAZOLE 500 MG TABLET (NDC 65862069550) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.